BN Business News
Add your company to Business Communicator →

Regulation & law · 21/11/2002Updated: 10/17/2026 · 1 min read

RMZ Biotech, Inc. to Receive Partially Exclusive Patent License for Dengue Virus Diagnostic Test Kits

Summary

The US Department of the Navy has announced its intention to grant RMZ Biotech, Inc. a non-transferable license to manufacture and distribute Dengue Virus diagnostic test kits worldwide, based on a Government-Owned patent issued in 1999.

Original source language: Federal Register — All DocumentsOpen original release →

Explore insights

Business insights →